Imogen Swift is a research scientist specializing in biomarkers and preclinical development with over 7 years of experience in neuroscience. Currently, they lead the biomarker strategy for the frontotemporal dementia clinical pipeline at Vesper Bio. Their previous roles include serving as a research technician and assistant at UCL, where they contributed to neurodegenerative research through extensive sample processing and biomarker analysis. Imogen earned a PhD in Neuroscience from UCL and holds a Master's degree in Molecular Neuroscience from the University of Bristol, along with a Bachelor's degree in Biochemistry from the University of Exeter.
This person is not in the org chart
This person is not in any teams
This person is not in any offices